Arrhythmias & electrophysiology
Efficacy of catheter ablation for ventricular tachycardia in ischemic cardiomyopathy patients without an implantable cardioverter-defibrillator (ICD) implantation
Main finding · VT recurrenceResult — go to the resultHazard ratio 0.14 95% CI 0.02–0.98Authors' conclusion
Patients with ICM undergoing VT ablation without a backup ICD experienced a notably low rate of arrhythmic death. Most recurrences proved nonlethal.
Study context
- Population
- Patients with ischemic cardiomyopathy undergoing ventricular tachycardia (VT) ablation without an ICD
- Participants
- 114 patients
- Exposure
- Endo-epicardial vs endocardial-only VT ablation
- Endo-epicardialn = 12
- Outcome
- VT recurrence
- Follow-up
- During
Main finding
As reported in the abstract
median follow-up 53.8 months (24.8-84.2 months)
Hazard ratio
0.14
95% CI 0.02–0.98
P = 0.048
By group
Endo-epicardialvs Endocardial
HR 0.14 (95% CI 0.02–0.98); P = 0.048
- VT recurrence, overall
- 45 patients (39.5%)
Observational data: associations, not effects.
Secondary outcomes
All-cause mortality · median follow-up 53.8 months
- Deaths, overall
- 6 patients (5.3%)
- Sudden cardiac deaths
- 2
Original publication
Efficacy of catheter ablation for ventricular tachycardia in ischemic cardiomyopathy patients without an ICD implantation. Heart Rhythm. Published 9 May 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →